Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124902163 | 12490216 | 3 | F | 20160303 | 20160831 | 20160622 | 20160906 | EXP | CA-PFIZER INC-2016145236 | PFIZER | 59.00 | YR | F | Y | 0.00000 | 20160906 | CN | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124902163 | 12490216 | 1 | PS | XELJANZ | TOFACITINIB CITRATE | 1 | Oral | 5 MG, 2X/DAY | 203214 | 5 | MG | TABLET | BID | ||||||
| 124902163 | 12490216 | 2 | SS | CELEBREX | CELECOXIB | 1 | Oral | UNK | 20998 | CAPSULE, HARD | |||||||||
| 124902163 | 12490216 | 3 | SS | PREGABALIN. | PREGABALIN | 1 | Oral | UNK | 21446 | ||||||||||
| 124902163 | 12490216 | 4 | SS | PREDNISONE. | PREDNISONE | 1 | Oral | 5 MG, DAILY | 0 | 5 | MG | ||||||||
| 124902163 | 12490216 | 5 | C | ARAVA | LEFLUNOMIDE | 1 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124902163 | 12490216 | 1 | Rheumatoid arthritis |
| 124902163 | 12490216 | 2 | Rheumatoid arthritis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124902163 | 12490216 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124902163 | 12490216 | Abdominal pain | |
| 124902163 | 12490216 | Faeces soft | |
| 124902163 | 12490216 | Fatigue | |
| 124902163 | 12490216 | Frequent bowel movements | |
| 124902163 | 12490216 | Grip strength decreased | |
| 124902163 | 12490216 | Musculoskeletal stiffness | |
| 124902163 | 12490216 | Nasopharyngitis | |
| 124902163 | 12490216 | Oedema peripheral | |
| 124902163 | 12490216 | Onychoclasis | |
| 124902163 | 12490216 | Retinopathy | |
| 124902163 | 12490216 | Synovial cyst | |
| 124902163 | 12490216 | Vision blurred | |
| 124902163 | 12490216 | Vitreous adhesions |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124902163 | 12490216 | 1 | 20160402 | 0 | ||
| 124902163 | 12490216 | 4 | 201601 | 0 |